BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25440223)

  • 1. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
    Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
    Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
    Chen L; Jin H
    Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
    Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
    Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer.
    Guo Z; Zhao C; Wang Z
    Tumour Biol; 2014 Oct; 35(10):10395-407. PubMed ID: 25053595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis.
    Zhang X; Wang Q; Zhang S
    Medicine (Baltimore); 2019 Feb; 98(6):e14337. PubMed ID: 30732158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically Correlated MicroRNAs in the Diagnosis of Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Jiang M; Li X; Quan X; Li X; Zhou B
    Biomed Res Int; 2018; 2018():5930951. PubMed ID: 30050938
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of microRNAs as biomarkers for cholangiocarcinoma detection: A diagnostic meta-analysis.
    Zhou J; Liu Z; Yang S; Li X
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):156-162. PubMed ID: 27939910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
    Wu K; Li L; Li S
    Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.
    Shi HB; Yu JX; Yu JX; Feng Z; Zhang C; Li GY; Zhao RN; Yang XB
    World J Surg Oncol; 2017 Aug; 15(1):147. PubMed ID: 28774300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA biomarkers for detection of non-small cell lung cancer.
    Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
    PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
    Yin C; Fang C; Weng H; Yuan C; Wang F
    Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
    Patnaik SK; Kannisto ED; Mallick R; Vachani A; Yendamuri S
    PLoS One; 2017; 12(7):e0181926. PubMed ID: 28742859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
    Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
    Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNAs as diagnostic biomarkers in screening of head and neck cancer: a meta-analysis.
    Zhang M; Zhao LJ; Liang WQ; Mao ZP
    Genet Mol Res; 2015 Dec; 14(4):16562-76. PubMed ID: 26681002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
    Su K; Zhang T; Wang Y; Hao G
    World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review.
    Huang Y; Hu Q; Deng Z; Hang Y; Wang J; Wang K
    Technol Cancer Res Treat; 2014 Jun; 13(3):277-87. PubMed ID: 24066954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta-analysis.
    Wang Q; Ma J; Jiang Z; Wu F; Ping J; Ming L
    Medicine (Baltimore); 2017 Jun; 96(24):e7173. PubMed ID: 28614255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.